Olfaction Disorders: Clinical Trials

4 trials for Olfaction Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 4
Phase 32Recruiting 2

Follow Olfaction Disorders: new trials by email Literature Review of Olfaction Disorders trials Research Report on Olfaction Disorders

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label
Trigeminal Nerve Stimulation-enhanced Smell Training - Olfactory Impairment
Phase 2RecruitingMedical University of South Carolina602026-07-102026-08-12
Impact of Smell Testing on Health Outcomes
Patient-centered information and education - Olfactory Dysfunction, Wellbeing
Phase 2RecruitingMonell Chemical Senses Center10002026-05-292026-10-06
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
Trigeminal Nerve Stimulation (TNS), Active Smell Training (ST), Placebo Smell Training (PBO) - Smell Dysfunction, Olfactory Disorder
Phase 2 / Phase 3RecruitingMedical University of South Carolina1452023-10-022026-04-02
GnRH Therapy on Cognition in Down Syndrome
GnRH, gonadorelin acetate, 0.9% NaCl - Down Syndrome, Cognitive Decline
Phase 2 / Phase 3RecruitingNelly Pitteloud562020-08-272024-02-12

Narrower conditions

Anosmia (2)  ·  Alzheimer Disease (1)  ·  COVID-19 (1)  ·  Cognitive Dysfunction (1)  ·  Down Syndrome (1)  ·  Post-Acute COVID-19 Syndrome (1)  ·  Psychological Well-Being (1)

Broader conditions

Nervous System Diseases (4)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Sensation Disorders (4)  ·  Signs and Symptoms (4)  ·  Abnormalities, Multiple (1)  ·  Behavior (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chromosome Disorders (1)  ·  Chronic Disease (1)  ·  Cognition Disorders (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Coronaviridae Infections (1)

Interventions

Educational Status (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  Olfactory Training (1)  ·  Saline Solution (1)  ·  Transcutaneous Electric Nerve Stimulation (1)

Sponsors

Medical University of South Carolina (2)  ·  Monell Chemical Senses Center (1)  ·  Nelly Pitteloud (1)

Countries

United States (3)  ·  Switzerland (1)

Top investigators

Danielle Reed (1)  ·  Nelly Pitteloud, MD (1)  ·  Pamela Dalton (1)  ·  Valentina Parma (1)

Results publications

PMID 36048943

NIH funding

R01DC021179 (1), R44DC022498 (1)